Safety and Tolerability of CFTX-1554 in Healthy Subjects

NCT05260658 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CFTX-1554
DRUG: Placebo

Sponsor

Confo Therapeutics